Etiome (Venture)

Funding Details
Awarder
Inbox
Date Award
April 24, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$50,000,000

Company Info
Founding Year
2021
Founders
Avak Kahvejian, Ph.D.
Company Description
Etiome is redefining how we detect and preempt disease progression to build a healthier future for patients with chronic and progressive diseases. Its Temporal Biodynamics™ platform is the first end-to-end technology to characterize disease with increased resolution over time and accelerate the development of preemptive medicines that promise better health outcomes.
Market
Healthcare
Location
Cambridge, MA, USA
Coinvestors
Flagship Pioneering

Links